Ana Sayfa
Piyasalar
Grafikler ve Fikirler
Algo
Haberler
Store
Aracı Kurumlar
İndir
Ekonomik Takvim
Alım-Satım Sinyalleri
Web Terminali
Heatmap
Arama yapmak için
/
tuşuna basın: @kullanıcı, $sembol, ...
Ara
Giriş yap
Hesap oluştur
Türkçe
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
FTXH
#5356
First Trust Nasdaq Pharmaceuticals ETF
34.6
3
USD
+1.44%
Sektör:
Finansal
Baz:
USD
Kar Para Birimi:
USD
Günlük Aralık
Yıllık Aralık
Günlük Değişim
+1.44%
Aylık Değişim
+2.15%
6 aylık değişim
+19.95%
Yıllık Değişim
+41.00%
Önceki Kapanış
34.1
4
Open
34.6
3
Bid
Ask
Low
34.6
3
High
34.6
3
Hacim
1
Piyasalar
ABD Borsası
Finansal
FTXH
Open full chart
Top holdings
Market Value
Shares
Weight %
MRK
Merck & Co Inc
1.65 M
15.67 K
7.71%
JNJ
Johnson & Johnson
1.54 M
7 440.00
7.19%
BMY
Bristol-Myers Squibb Co
1.51 M
27.94 K
7.04%
ABBV
AbbVie Inc
1.43 M
6 266.00
6.69%
PFE
Pfizer Inc
1.33 M
53.24 K
6.19%
LLY
Eli Lilly & Co
967.21 K
900.00
4.52%
CAH
Cardinal Health Inc
910.37 K
4 430.00
4.25%
REGN
Regeneron Pharmaceuticals Inc
876.07 K
1 135.00
4.09%
BIIB
Biogen Inc
861.30 K
4 894.00
4.02%
VTRS
Viatris Inc
777.84 K
62.48 K
3.63%
VRTX
Vertex Pharmaceuticals Inc
764.36 K
1 686.00
3.57%
AMGN
Amgen Inc
749.87 K
2 291.00
3.50%
UTHR
United Therapeutics Corp
718.69 K
1 475.00
3.36%
GILD
Gilead Sciences Inc
716.19 K
5 835.00
3.35%
ZTS
Zoetis Inc
530.21 K
4 214.00
2.48%
Jazz Pharmaceuticals PLC
527.00 K
3 100.00
2.46%
ILMN
Illumina Inc
430.73 K
3 284.00
2.01%
PTCT
PTC Therapeutics Inc
357.70 K
4 709.00
1.67%
INCY
Incyte Corp
329.30 K
3 334.00
1.54%
CRL
Charles River Laboratories Int
322.36 K
1 616.00
1.51%
Haberler
AI And The Future Of Healthcare
Global PMI: Tracking The Sectors Hit Hardest By The Middle East War
Can Forgotten Biotech Break Out?
Concerns Shift From Obsolescence To Oil
CDT Insider Sentiment March 2026: The Probability Race And Barbell Strategies
Trump's 100% Pharma Tariffs Will Have A Limited Effect On The Sector
Finally Coming Into View? 'Old-Economy' Stocks Show Their Colors
Europe’s Last Chance To Revive Its Pharmaceutical Innovation Power
Q4 2025 Earnings: AI Disruption Vs. Traditional Fundamentals
Pharma's Godfather Moment: Pulled Back Into Tariff Uncertainty
The K-Shaped Consumer Economy: GLP-1s, AI And The Future Of Consumer Spending
The Trump Administration’s Affordability Plan